This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2010 Apr;16(4):376-7.

doi: 10.1038/nm0410-376.

Molecular oracles for multiple sclerosis therapy

Hartmut Wekerle, Reinhard Hohlfeld

PMID: 20376043
DOI: 10.1038/nm0410-376

Comment

Molecular oracles for multiple sclerosis therapy

Hartmut Wekerle et al. Nat Med. 2010 Apr.

. 2010 Apr;16(4):376-7.

doi: 10.1038/nm0410-376.

Authors

Hartmut Wekerle, Reinhard Hohlfeld

PMID: 20376043
DOI: 10.1038/nm0410-376

No abstract available

PubMed Disclaimer

Comment on

T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis.
Axtell RC, de Jong BA, Boniface K, van der Voort LF, Bhat R, De Sarno P, Naves R, Han M, Zhong F, Castellanos JG, Mair R, Christakos A, Kolkowitz I, Katz L, Killestein J, Polman CH, de Waal Malefyt R, Steinman L, Raman C. Axtell RC, et al. Nat Med. 2010 Apr;16(4):406-12. doi: 10.1038/nm.2110. Epub 2010 Mar 28. Nat Med. 2010. PMID: 20348925 Free PMC article.

Similar articles

Immunological study of IFNbeta-1a-treated and untreated multiple sclerosis patients: clarifying IFNbeta mechanisms and establishing specific dendritic cell immunotherapy.
Berghella AM, Totaro R, Pellegrini P, Contasta I, Russo T, Carolei A, Adorno D. Berghella AM, et al. Neuroimmunomodulation. 2005;12(1):29-44. doi: 10.1159/000082362. Neuroimmunomodulation. 2005. PMID: 15756051 Clinical Trial.
Expression of chemokine receptors on Th1/Th2 CD4+ lymphocytes in patients with multiple sclerosis.
Andalib A, Doulabi H, Najafi M, Tazhibi M, Rezaie A. Andalib A, et al. Iran J Immunol. 2011 Mar;8(1):1-10. Iran J Immunol. 2011. PMID: 21427490
T Helper Cells: The Modulators of Inflammation in Multiple Sclerosis.
Kunkl M, Frascolla S, Amormino C, Volpe E, Tuosto L. Kunkl M, et al. Cells. 2020 Feb 19;9(2):482. doi: 10.3390/cells9020482. Cells. 2020. PMID: 32093011 Free PMC article. Review.
CD30 antigen and multiple sclerosis: CD30, an important costimulatory molecule and marker of a regulatory subpopulation of dendritic cells, is involved in the maintenance of the physiological balance between TH1/TH2 immune responses and tolerance. The role of IFNbeta-1a in the treatment of multiple sclerosis.
Pellegrini P, Totaro R, Contasta I, Berghella AM, Carolei A, Adorno D. Pellegrini P, et al. Neuroimmunomodulation. 2005;12(4):220-34. doi: 10.1159/000085654. Neuroimmunomodulation. 2005. PMID: 15990453
Multiple sclerosis and interferon beta-1b, past, present and future.
Horowski R. Horowski R. Clin Neurol Neurosurg. 2002 Jul;104(3):259-64. doi: 10.1016/s0303-8467(02)00049-5. Clin Neurol Neurosurg. 2002. PMID: 12127665 Review. No abstract available.

See all similar articles

Cited by

The conundrum of iron in multiple sclerosis--time for an individualised approach.
van Rensburg SJ, Kotze MJ, van Toorn R. van Rensburg SJ, et al. Metab Brain Dis. 2012 Sep;27(3):239-53. doi: 10.1007/s11011-012-9290-1. Epub 2012 Mar 17. Metab Brain Dis. 2012. PMID: 22422107 Free PMC article. Review.

References

1. PLoS Biol. 2005 Jan;3(1):e2 - PubMed
1. Am J Pathol. 2008 Jan;172(1):146-55 - PubMed
1. J Immunol. 2004 Mar 1;172(5):2731-8 - PubMed
1. Brain. 2004 Jul;127(Pt 7):1463-78 - PubMed
1. J Immunol. 2009 Oct 15;183(8):5418-27 - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Medical
- MedlinePlus Health Information